Literature DB >> 24447175

Improved pan-specific MHC class I peptide-binding predictions using a novel representation of the MHC-binding cleft environment.

S Carrasco Pro1, M Zimic, M Nielsen.   

Abstract

Major histocompatibility complex (MHC) molecules play a key role in cell-mediated immune responses presenting bounded peptides for recognition by the immune system cells. Several in silico methods have been developed to predict the binding affinity of a given peptide to a specific MHC molecule. One of the current state-of-the-art methods for MHC class I is NetMHCpan, which has a core ingredient for the representation of the MHC class I molecule using a pseudo-sequence representation of the binding cleft amino acid environment. New and large MHC-peptide-binding data sets are constantly being made available, and also new structures of MHC class I molecules with a bound peptide have been published. In order to test if the NetMHCpan method can be improved by integrating this novel information, we created new pseudo-sequence definitions for the MHC-binding cleft environment from sequence and structural analyses of different MHC data sets including human leukocyte antigen (HLA), non-human primates (chimpanzee, macaque and gorilla) and other animal alleles (cattle, mouse and swine). From these constructs, we showed that by focusing on MHC sequence positions found to be polymorphic across the MHC molecules used to train the method, the NetMHCpan method achieved a significant increase in the predictive performance, in particular, of non-human MHCs. This study hence showed that an improved performance of MHC-binding methods can be achieved not only by the accumulation of more MHC-peptide-binding data but also by a refined definition of the MHC-binding environment including information from non-human species.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Artificial Neural Networks; Binding specificity; CTL epitopes; Epitope prediction; MHC class I; Non-human primates

Mesh:

Substances:

Year:  2014        PMID: 24447175      PMCID: PMC3925504          DOI: 10.1111/tan.12292

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  22 in total

Review 1.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Efficient peptide-MHC-I binding prediction for alleles with few known binders.

Authors:  Laurent Jacob; Jean-Philippe Vert
Journal:  Bioinformatics       Date:  2007-12-14       Impact factor: 6.937

3.  The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding.

Authors:  Hao Zhang; Ole Lund; Morten Nielsen
Journal:  Bioinformatics       Date:  2009-03-17       Impact factor: 6.937

4.  Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods.

Authors:  Hao Zhang; Claus Lundegaard; Morten Nielsen
Journal:  Bioinformatics       Date:  2008-11-07       Impact factor: 6.937

5.  Learning MHC I--peptide binding.

Authors:  Nebojsa Jojic; Manuel Reyes-Gomez; David Heckerman; Carl Kadie; Ora Schueler-Furman
Journal:  Bioinformatics       Date:  2006-07-15       Impact factor: 6.937

6.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

7.  MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides.

Authors:  Guang Lan Zhang; Asif M Khan; Kellathur N Srinivasan; J Thomas August; Vladimir Brusic
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

8.  IPD--the Immuno Polymorphism Database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

9.  NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence.

Authors:  Morten Nielsen; Claus Lundegaard; Thomas Blicher; Kasper Lamberth; Mikkel Harndahl; Sune Justesen; Gustav Røder; Bjoern Peters; Alessandro Sette; Ole Lund; Søren Buus
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  6 in total

1.  In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes.

Authors:  Julien Schmidt; Philippe Guillaume; Danijel Dojcinovic; Julia Karbach; George Coukos; Immanuel Luescher
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

2.  Differences in MHC-B diversity and KIR epitopes in two populations of wild chimpanzees.

Authors:  Vincent Maibach; Kevin Langergraber; Fabian H Leendertz; Roman M Wittig; Linda Vigilant
Journal:  Immunogenetics       Date:  2019-12-03       Impact factor: 2.846

3.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

4.  Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches.

Authors:  Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-09-01       Impact factor: 4.818

5.  Reduced bonobo MHC class I diversity predicts a reduced viral peptide binding ability compared to chimpanzees.

Authors:  Vincent Maibach; Linda Vigilant
Journal:  BMC Evol Biol       Date:  2019-01-10       Impact factor: 3.260

Review 6.  Therapeutic Vaccine Strategies against Human Papillomavirus.

Authors:  Hadeel Khallouf; Agnieszka K Grabowska; Angelika B Riemer
Journal:  Vaccines (Basel)       Date:  2014-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.